NCT03664687 2026-02-09
REaCT-ZOL
Ottawa Hospital Research Institute
Phase 4 Completed
Clinical Trials
10 trialsNCT04549207 2025-11-28
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT00733538 2024-04-12
IFM-01-04
Centre Hospitalier Universitaire de Nice
Phase 4 Completed
NCT02286830 2023-02-17
Magnolia
Odense University Hospital
Phase 4 Completed
NCT01087008 2020-04-06
AZABACHE
PETHEMA Foundation
Phase 4 Completed
NCT03932071 2019-05-06
Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Unknown
NCT02480634 2019-01-16
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 4 Unknown
NCT01907880 2017-07-07
ER11-03
Ottawa Hospital Research Institute
Phase 4 Completed
NCT00762346 2013-12-10
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis
Sun Yat-sen University
Phase 4 Completed
NCT00912938 2010-02-17
Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients
Korean Breast Cancer Study Group
Phase 4 Unknown